CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to BBIO

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
6mo
BBIOPDUFA
Phase 3

FDA PDUFA Date encaleret (standard)

Encaleret
May 8
SEC
00%
Competitive Landscape

0 competitors in Autosomal Dominant Hypocalcemia (ADH)

View Full Landscape
Drug Information

Target Indication

Autosomal Dominant Hypocalcemia (ADH)

Clinical Trial

NCT04581629

Last updated: 1/22/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.